Publications
Publications
Show Results For
- All HBS Web
(6,057)
- Faculty Publications (915)
Numbers
→
- 2001
- Working Paper
Contextuality Within Activity Systems
By: Michael E. Porter and Nicolaj Siggelkow
Research on the interactions among activities in firms and the extent to which these interactions help create and sustain competitive advantage has rapidly expanded in recent years. In this research, the two most common approaches have been the complementarity... View Details
- February 2001 (Revised August 2003)
- Case
United Grain Growers Limited (A)
By: Peter Tufano and Joshua Musher
United Grain Growers Ltd. (UGG), a Canadian grain distributor, audited its exposure to a number of key risks, especially the impact of weather on grain volumes and operating income. Understanding these risks was crucial because the company was in the midst of a major... View Details
- February 2001 (Revised August 2001)
- Case
Dialpad Communications (A)
By: Alan D. MacCormack and Kerry Herman
Describes the evolution of Dialpad, a voice-over-Internet-protocol telephony company. Set in September 2000, CEO Brad Garlinghouse faces a dilemma: what to do about the large number of international users who use Dialpad to call the United States for free. He must also... View Details
- February 2001 (Revised May 2001)
- Case
Wipro Technologies (A)
By: Lynn S. Paine, Carin-Isabel Knoop and Suma Raju
The new general manager of Wipro's software services division has been brought on board from General Electric to develop the division into a leading provider of software services to the world's largest corporations. A native of India who received management training in... View Details
- February 2001 (Revised November 2009)
- Case
Amazon.com (D)
By: Jeffrey F. Rayport, Dickson Louie and William A. Sahlman
At the end of 1999, Amazon.com founder and CEO Jeff Bezos--just named Time Magazine's Man of the Year--ponders the next moves for his company. Having expanded into numerous categories in 1999, ranging from Z-shops to Auctions to E-cards as well as increasing the number... View Details
- January 2001
- Case
Abgenix and the XenoMouse
By: Robert J. Dolan
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to... View Details
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
- November 2000 (Revised November 2005)
- Case
Tellme Networks, Inc.
By: Thomas R. Eisenmann and Nicole Tempest
Tellme, an early-stage, venture-backed company based in Silicon Valley, leverages speech-recognition technologies to provide: 1) a "voice portal" with news and other information accessible through any telephone, and 2) turnkey application development and hosting... View Details
- October 2000 (Revised September 2002)
- Case
NTT DoCoMo (A): The Future of the Wireless Internet?
By: Stephen P. Bradley and Matthew Sandoval
NTT DoCoMo was established in 1992 and became publicly held in 1998. This case tracks how DoCoMo became the number one mobile phone company in Japan and how its i.mode service revolutionized the cellular phone market. View Details
- October 2000 (Revised March 2001)
- Case
BizRate.com
By: Youngme E. Moon
BizRate is a market research firm that collects point-of-purchase customer feedback data from retailing merchants. It then makes its findings available to consumers in the form of "BizRate star ratings," which are displayed on its website. To date, its primary revenue... View Details
- October 2000 (Revised June 2017)
- Case
Vyaderm Pharmaceuticals: The EVA Decision
By: Robert Simons and Indra A. Reinbergs
In 2016, the new CEO of Vyaderm Pharmaceuticals introduces an Economic Value Added (EVA) program to focus the company on long-term shareholder value. The EVA program consists of three elements: EVA centers (business units), EVA drivers (operational practices that... View Details
- September 2000
- Case
Intellectual Property Exchange (A), The
By: Lynda M. Applegate and Gavin Clarkson
As the marketplace for intellectual assets explodes, the mechanisms for liquidity and exchange have not kept pace. Bryan Benoit, partner at PricewaterhouseCoopers (PwC), believes that he has a solution. Working initially with a shoestring development budget, he has... View Details
- June 2000
- Case
Rebirth of the Swiss Watch Industry, 1980-1992 (A)
By: Michael L. Tushman and Daniel Radov
The Swiss watch industry has been devastated by new entrants from Asia in the low- and mid-priced watch segments. Japanese and Hong Kong firms have used quartz technology to lower costs dramatically. Nicolas Hayek, president of a Swiss consulting firm, is asked to help... View Details
- May 2000 (Revised October 2001)
- Case
Dell Ventures
By: Paul A. Gompers, Carin-Isabel Knoop and Cate Reavis
Describes the rationale behind the strategy and structure of Dell Computer Corp.'s VC arm, Dell Ventures. While Dell Ventures had a phenomenal year one, it faced a number of challenges including dealing with market risks, finding and retaining talent, maintaining... View Details
- April 2000 (Revised August 2002)
- Case
The Holland House
By: William J. Poorvu and Michael A. Everett-Lane
In November 1993, Edward Geffner, executive director of Project Renewal, Inc. (PRI), is proposing that his not-for-profit firm develop Holland House at 351 West 42nd Street in New York City into a single- room occupancy hotel for homeless people. He has put together a... View Details
- January 2000 (Revised November 2000)
- Exercise
WineMaster.com (A-1): Confidential Instructions for WineMaster
A two-person negotiation exercise involving the potential sale of a small e-commerce company to a large company. The parties need to negotiate four issues: the number of shares in the deal, the vesting period for the shares, whether the seller will get a seat on the... View Details
- January 2000 (Revised November 2000)
- Exercise
WineMaster.com (A-2): Confidential Instructions for HomeBase
A two-person negotiation exercise involving the potential sale of a small e-commerce company to a large company. The parties need to negotiate four issues: the number of shares in the deal, the vesting period for the shares, whether the seller will get a seat on the... View Details
- December 1999 (Revised August 2001)
- Case
Millennium Pharmaceuticals, Inc. (A)
By: Stefan H. Thomke and Ashok Nimgade
Focuses on Millennium's strategy to grow and revolutionize drug development through the use of new technologies such as genomics. Describes how Millennium Pharmaceuticals--a fast-growing biotechnology firm in Cambridge, MA--has used strategic alliances to finance the... View Details
- December 1999 (Revised February 2001)
- Case
CVS: The Web Strategy
By: John A. Deighton and Anjali C. Shah
How should America's second-largest pharmacy chain respond to the challenge from online drugstores? What threat does the web pose to bricks and mortar distribution of prescription drugs and the other items that make up 50% of a drugstore's sales? This case describes... View Details
- November 1999
- Case
Lucent Technologies: Optical Networking Group
By: Marco Iansiti and Barbara Feinberg
Set in June 1999, this case describes the development of a new platform product, the Wavestar OLS 400G, that responded both to a demand for greater "bandwidth" and aggressive competitors seeking to supply it. The 400G's development process took only 14 months and... View Details